Medtronic plc 2M6.DE

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2026-04-30

Average Intrinsic Value
$58.50B
Market Cap
$110.93B
Margin of Safety
-89.6%
Intrinsic / Market Ratio
0.53

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

59.20B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

59.37B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

56.93B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

58.50B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

58.50B USD

from the sum above

Market Cap

110.93B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.53×

the ratio the screener ranks by; Margin of Safety -89.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 59.20B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)77.26B USD
−②Net Debt Today19.35B USD
+③Growth Value1.29B USD
=Value59.20B USD

EPV of the Operations (NOPAT over WACC)

77.26B USD

Net debt today

-19.35B USD

Growth Value

+1.29B USD

Value

59.20B USD

①EPV (earnings power value)

77.26B USD

②Net Debt Today

19.35B USD

③Growth Value

1.29B USD

Market value

Market Cap110.93B USD

Today's price times the shares.

Value vs market

Margin of Safety-87.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 59.37B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE40.37B USD
+②Equity at Year 15, Today19.00B USD
=Value59.37B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

40.37B USD

②Equity at Year 15, Today

19.00B USD

Market value

Market Cap110.93B USD

Today's price times the shares.

Value vs market

Margin of Safety-86.8%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 56.93B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF44.21B USD
+②Invested Capital at Year 15, Today32.07B USD
−③Net Debt Today19.35B USD
=Value56.93B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

44.21B USD

②Invested Capital at Year 15, Today

32.07B USD

③Net Debt Today

19.35B USD

Market value

Market Cap110.93B USD

Today's price times the shares.

Value vs market

Margin of Safety-94.9%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.74%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.57×Market Risk Premium 6.00%= 7.94%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 1.30B USDPretax Income 6.14B USD= 21.17%

The tax the interest saves.

Interest Expense =EBIT 6.86B USD−Pretax Income 6.14B USD= 715.71M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 715.71M USDTotal Debt 28.18B USD×(1 − Tax Rate for WACC 21.17%)= 2.00%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 28.18B USDMarket Cap + Total Debt 110.93B USD + 28.18B USD= 20.26%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 79.74%×Cost of Equity 7.94%+Debt Weight 20.26%×Cost of Debt 2.00%= 6.74%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-07-31.

Total Assets 93.40B USD − Total Liabilities 42.50B USD = Book Value Today 50.90B USD

Total Debt 28.18B USD − Cash and Short-Term Investments 8.83B USD = Net Debt Today 19.35B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-2.4%at most 5%passes1,280,046,863 / 1,311,337,531
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.7%at least -10.0%passes(7.34B USD − 4.81B USD) ÷ 93.40B USD
Price to bookMarket Cap ÷ Book Value Today2.18×at most 3×passes110.93B USD ÷ 50.90B USD
Operating marginOperating Income ÷ Revenue18.8%above 10.0%passes6.83B USD ÷ 36.40B USD
Revenue growthRevenue ÷ Revenue a Year Before − 18.4%above 10.0%does not pass36.40B USD / 33.57B USD
Net cash(Cash − Total Debt) ÷ Market Cap-23.9%above -30%passes(1.69B USD − 28.18B USD) ÷ 110.93B USD
Operating efficiencyOperating Income ÷ Gross Profit28.9%above 25.0%passes6.83B USD ÷ 23.67B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

77 USD

Enterprise value

117.85B USD

market cap plus net debt

EV / EBITDA

11.31×

Price / book

2.26×

the provider's book

Price / earnings

21.66×

Return on equity

10.7%

the provider's, not the engine's

Profit margin

13.9%

Revenue growth

13.7%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2023202420252026
Income statement

Revenue

31.26B32.40B33.57B36.40B

Gross profit

20.53B21.17B21.93B23.67B

Operating income

5.84B5.53B6.55B6.83B

EBITDA

operating income before depreciation and amortisation

8.71B8.21B9.23B9.82B

Pretax income

5.37B4.84B5.63B6.14B

Net income

3.76B3.68B4.67B4.81B

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

4.01B3.97B5.15B5.09B

R&D

2.70B2.74B2.73B2.88B
Balance sheet, year end

Total assets

91.04B90.07B91.77B93.12B

Total liabilities

39.32B39.60B43.47B43.00B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

51.53B50.26B48.07B49.51B

Total debt

24.39B25.05B28.54B27.99B

Cash and equivalents

1.54B1.29B2.22B1.95B

Net PP&E

fixed assets after depreciation

5.57B6.14B6.84B7.42B

Working capital

current assets less current liabilities

12.64B11.16B10.95B13.14B
Cash flow

Operating cash flow

6.05B6.79B7.05B7.34B

Capital expenditure

paid out, so below zero

-1.46B-1.59B-1.86B-1.91B

Depreciation and amortisation

2.70B2.65B2.86B2.96B

Free cash flow

operating cash flow plus capital expenditure

4.58B5.21B5.19B5.43B